RT Journal Article
SR Electronic
T1 Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.25.22281489
DO 10.1101/2022.10.25.22281489
A1 Ogero, M
A1 Isaaka, L
A1 Mumelo, L
A1 Kimego, D
A1 Njoroge, T
A1 Mbevi, G
A1 Wanyama, C
A1 Lucinde, R
A1 Gathuri, H
A1 Otiende, M
A1 Nzioki, C
A1 Wachira, A
A1 Mumbi, F
A1 Oeri, G
A1 Mwangi, N
A1 Gitari, R
A1 Mugambi, D
A1 Namu, S
A1 Ithondeka, A
A1 Kariuki, H
A1 Kiama, Z
A1 Mwende, L
A1 Jowi, E
A1 Muthui, B
A1 Kaara, A
A1 Sitienei, E
A1 Thuranira, L
A1 Oginga, I
A1 Njagi, J
A1 Kamau, E
A1 Namulala, E
A1 Oketch, G
A1 Wandera, O
A1 Adhiambo, S
A1 Adem, A
A1 Ochieng, M
A1 Otedo, A
A1 Otiende, K
A1 Odondi, A
A1 Makokha, F
A1 Lubanga, D
A1 Nyikui, J
A1 Masoso, W
A1 Manyonge, M
A1 Inginia, R
A1 Manuthu, E
A1 Wafula, D
A1 Agutu, C
A1 Malangachi, R
A1 Biko, S
A1 Simiyu,
A1 Obare, J
A1 Kimutai, D
A1 Gituma, B
A1 Kyalo, J
A1 Timbwa, M
A1 Otieno, J
A1 Liru, M
A1 Nyabinda, C
A1 Otieno, S
A1 Aman, R
A1 Mwangangi, M
A1 Amoth, P
A1 Were, I
A1 Mwangi, C
A1 Kasera, K
A1 Ng’ang’a, W
A1 Tsegaye, A
A1 Sherry, C
A1 Singa, B
A1 Tickell, K
A1 Walson, J
A1 Berkley, J
A1 Were, F
A1 Mturi, N
A1 Hamaluba, M
A1 Tsofa, B
A1 Mwangangi, J
A1 Bejon, P
A1 Barasa, E
A1 English, M
A1 Nyaguara, A
A1 Kagucia, EW
A1 Scott, JAG
A1 Akech, S
A1 Etyang, AO
A1 Agweyu, A
YR 2022
UL http://medrxiv.org/content/early/2022/10/27/2022.10.25.22281489.abstract
AB Background The impact of COVID-19 in Africa remains poorly defined. We sought to describe trends in hospitalisation due to all medical causes, pneumonia-specific admissions, and inpatient mortality in Kenya before and during the first five waves of the COVID-19 pandemic in Kenya.Methods We conducted a hospital-based, multi-site, longitudinal observational study of patients admitted to 13 public referral facilities in Kenya from January 2018 to December 2021. The pre-COVID population included patients admitted before 1 March 2020. We fitted time series models to compare observed and predicted trends for each outcome. To estimate the impact of the COVID-19 pandemic, we calculated incidence rate ratios (IRR) and corresponding 95% confidence intervals (CI) from negative binomial mixed-effects models.Results Out of 302,703 patients hospitalised across the 13 surveillance sites (range 11547 to 57011), 117642 (39%) were admitted to adult wards. Compared with the pre-COVID period, hospitalisations declined markedly among adult (IRR 0.68, 95% CI 0.63 to 0.73) and paediatric (IRR 0.67, 95% CI 0.62 to 0.73) patients. Adjusted in-hospital mortality also declined among both adult (IRR 0.83, 95% CI 0.77 to 0.89) and paediatric (IRR 0.85, 95% CI 0.77 to 0.94) admissions. Pneumonia-specific admissions among adults increased during the pandemic (IRR 1.75, 95% CI 1.18 to 2.59). Paediatric pneumonia cases were lower than pre-pandemic levels in the first year of the pandemic and elevated in late 2021 (IRR 0.78, 95% CI 0.51 to 1.20).Conclusions Contrary to initial predictions, the COVID-19 pandemic was associated with lower hospitalisation rates and in-hospital mortality, despite increased pneumonia admissions among adults. These trends were sustained after the withdrawal of containment measures that disrupted essential health services, suggesting a role for additional factors that warrant further investigation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a DFID/MRC/NIHR/Wellcome Trust Joint Global Health Trials Award (MR/R006083/1), The World Bank Group (7198506), a core awarded from the Wellcome Trust (grants 20991/Z/20/Z and 203077/Z/16/Z), and an award to the CHAIN Network from the Bill & Melinda Gates Foundation (OPP1131320). Funders had no role in study design, conduct, analysis, interpretation or decision to publishAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This Scientific and Ethical Review Committee of the Kenya Medical Research Institute (approval number: KEMRI/SERU/CGMR-C/203/4085), the Oxford Tropical Research Ethics Committee (approval number: 44-20), and the London School of Hygiene and Tropical Medicine Research Ethics Committee (approval number: 26950) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors